The Claim
Engineered Escherichia coli expressing surface-displayed ClbS reduces intestinal inflammation and mucosal damage in mice with dextran sodium sulfate and colibactin-producing E. coli-induced colitis, as measured by lower histological injury scores and higher goblet cell counts.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A genetically modified strain of E. coli bacteria, designed to display a specific protein, reduces signs of intestinal damage and inflammation in mice with chemically induced colitis, as shown by improved tissue scores and increased mucus-producing cells.
See the scientific wording
Engineered Escherichia coli expressing surface-displayed ClbS mitigates intestinal inflammation and mucosal damage in mice with colitis induced by dextran sodium sulfate and colibactin-producing E. coli, as evidenced by reduced histological injury scores and increased goblet cell counts.
What the research says
1 studyStudy: Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut
Scientists modified harmless E. coli bacteria to act like sponges that soak up a harmful toxin made by other bad bacteria in the gut. This stopped the toxin from damaging the intestine in mice with colitis, making their guts healthier.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.